Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTAR study): a multicentre, randomised, double-blind, controlled trial

Added 468 days ago (29.04.2021)
Authors: Johannes F E Mann; Roland E Schmieder; Matthew McQueen; Leanne Dyal; Helmut Schumacher; Janice Pogue; Xingyu Wang; Aldo Maggioni; Andrzej Budaj; Suphachai Chaithiraphan; Kenneth Dickstein; Matyas Keltai; Kaj Metsärinne; Ali Oto; Alexander Parkhomenko; Leopoldo S Piegas; Tage L Svendsen; Koon K Teo; Salim Yusuf; ONTAR investigators
Read article